Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-blind randomized dose-finding trial of lithium in ALS
2008-001094-15Phase 2Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Mar 2008
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of lithium in amyotrophic lateral sclerosis (ALS) (2 arms), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoint: Primary composite endpoint. Started Mar 2008; status: active.
02
Drugs
lithium
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2008-001094-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001094-15.